HealthEquity, Inc. (HQY) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $85.38 (-1.83%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 9, 2026 | Sean Dodge | BMO Capital | $105.00 | +23.0% |
| Feb 18, 2026 | Peter Warendorf | Barclays | $110.00 | +28.8% |
| Jan 8, 2026 | Scott Schoenhaus | KeyBanc | $125.00 | +46.4% |
| Dec 8, 2025 | Peter Warendorf | Barclays | $118.00 | +38.2% |
| Oct 8, 2025 | Scott Schoenhaus | KeyBanc | $120.00 | +40.5% |
| Sep 3, 2025 | Glen Santangelo | Jefferies | $134.00 | +56.9% |
| Aug 28, 2025 | Daniel Perlin | RBC Capital | $109.00 | +27.7% |
| Mar 25, 2025 | Strong Buy | Raymond James | $115.00 | +34.7% |
| Dec 10, 2024 | Alexander Paris | Barrington | $112.00 | +31.2% |
| Sep 4, 2024 | George Hill | Deutsche Bank | $103.00 | +20.6% |
| Jun 20, 2024 | Stan Berenshteyn | Wells Fargo | $110.00 | +28.8% |
| Jun 4, 2024 | Scott Schoenhaus | KeyBanc | $100.00 | +17.1% |
| Jun 4, 2024 | Mark Marcon | Robert W. Baird | $104.00 | +21.8% |
| Jun 3, 2024 | Alexander Paris | Barrington | $100.00 | +17.1% |
| May 7, 2024 | Stan Berenshteyn | Wells Fargo | $105.00 | +23.0% |
| Apr 4, 2024 | Constantine Davides | JMP Securities | $101.00 | +18.3% |
| Mar 28, 2024 | Glen Santangelo | Jefferies | $95.00 | +11.3% |
| Mar 20, 2024 | Stephanie Davis | Barclays | $104.00 | +21.8% |
| Mar 20, 2024 | Sean Dodge | RBC Capital | $92.00 | +7.8% |
| Sep 21, 2023 | Mark Marcon | Robert W. Baird | $87.00 | +1.9% |
Top Analysts Covering HQY
HQY vs Sector & Market
| Metric | HQY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.23 | 2.24 | 2.40 |
| Analyst Count | 13 | 8 | 19 |
| Target Upside | +21.7% | +11475.0% | +17.1% |
| P/E Ratio | 31.98 | 3.88 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $343M | $348M | $351M | 10 |
| 2026-10-31 | $341M | $346M | $350M | 5 |
| 2027-01-31 | $361M | $366M | $370M | 5 |
| 2027-04-30 | $379M | $384M | $389M | 5 |
| 2027-07-31 | $372M | $377M | $382M | 5 |
| 2027-10-31 | $369M | $374M | $378M | 5 |
| 2028-01-31 | $387M | $392M | $396M | 4 |
| 2029-01-31 | $1.60B | $1.62B | $1.64B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $1.15 | $1.19 | $1.26 | 10 |
| 2026-10-31 | $1.14 | $1.16 | $1.18 | 4 |
| 2027-01-31 | $1.14 | $1.16 | $1.18 | 4 |
| 2027-04-30 | $1.29 | $1.31 | $1.33 | 4 |
| 2027-07-31 | $1.35 | $1.38 | $1.40 | 4 |
| 2027-10-31 | $1.30 | $1.33 | $1.34 | 4 |
| 2028-01-31 | $1.30 | $1.32 | $1.34 | 5 |
| 2029-01-31 | $6.10 | $6.20 | $6.32 | 4 |
Frequently Asked Questions
What is the analyst consensus for HQY?
The consensus among 13 analysts covering HealthEquity, Inc. (HQY) is Buy with an average price target of $109.89.
What is the highest price target for HQY?
The highest price target for HQY is $134.00, set by Glen Santangelo at Jefferies on 2025-09-03.
What is the lowest price target for HQY?
The lowest price target for HQY is $70.00, set by Charles Peters at Raymond James on 2021-12-14.
How many analysts cover HQY?
13 analysts have issued ratings for HealthEquity, Inc. in the past 12 months.
Is HQY a buy or sell right now?
Based on 13 analyst ratings, HQY has a consensus rating of Buy (2.23/5) with a +21.7% upside to the consensus target of $109.89.
What are the earnings estimates for HQY?
Analysts estimate HQY will report EPS of $1.19 for the period ending 2026-07-31, with revenue estimated at $348M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.